These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 7260907)
1. Synergistic effects with inhibitors of de novo pyrimidine synthesis, acivicin, and N-(phosphonacetyl)-L-aspartic acid. Loh E; Kufe DW Cancer Res; 1981 Sep; 41(9 Pt 1):3419-23. PubMed ID: 7260907 [TBL] [Abstract][Full Text] [Related]
2. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis. Kensler TW; Jayaram HN; Cooney DA Adv Enzyme Regul; 1982; 20():57-73. PubMed ID: 7113804 [TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate. Moyer JD; Handschumacher RE Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293 [No Abstract] [Full Text] [Related]
4. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells. Moyer JD; Smith PA; Levy EJ; Handschumacher RE Cancer Res; 1982 Nov; 42(11):4525-31. PubMed ID: 7127293 [TBL] [Abstract][Full Text] [Related]
5. Collateral sensitivity to N-(phosphonacetyl)-L-aspartic acid in a line of P388 leukemia cells selected for resistance to L-(alpha S, 5S)-alpha-amino-3- chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin). Ardalan B; Jayaram HN; Johnson RK Cancer Res; 1983 Apr; 43(4):1598-601. PubMed ID: 6831405 [TBL] [Abstract][Full Text] [Related]
6. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines. Peters GJ Nucleosides Nucleotides Nucleic Acids; 2018; 37(6):329-339. PubMed ID: 29723133 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of acivicin and N-(phosphonacetyl)-L-aspartic acid in a biochemically designed trial against a N-(phosphonacetyl)-L-aspartic acid-resistant variant of the Lewis lung carcinoma. Kensler TW; Reck LJ; Cooney DA Cancer Res; 1981 Mar; 41(3):905-9. PubMed ID: 7459876 [No Abstract] [Full Text] [Related]
9. Flux through the de novo pyrimidine pathway in vivo. Effect of N-phosphonacetyl-L-aspartate, a potent inhibitor of aspartate transcarbamylase. Monks A; Anderson LW; Strong J; Cysyk RL J Biol Chem; 1983 Nov; 258(22):13564-9. PubMed ID: 6417130 [TBL] [Abstract][Full Text] [Related]
10. Effect of inhibitors of the de novo pyrimidine biosynthetic pathway on serum uridine levels in mice. Karle JM; Anderson LW; Dietrick DD; Cysyk RL Cancer Res; 1981 Dec; 41(12 Pt 1):4952-5. PubMed ID: 6171344 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase. Rosenfeld H; Roberts J Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322 [TBL] [Abstract][Full Text] [Related]
12. Effect of plasma concentrations of uridine on pyrimidine biosynthesis in cultured L1210 cells. Karle JM; Anderson LW; Cysyk RL J Biol Chem; 1984 Jan; 259(1):67-72. PubMed ID: 6323418 [TBL] [Abstract][Full Text] [Related]
13. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells. Grant S; Rauscher F; Jakubowski A; Cadman E Cancer Res; 1981 Feb; 41(2):410-8. PubMed ID: 6160908 [TBL] [Abstract][Full Text] [Related]
14. The glutamine analog acivicin as antipyrimidine. Studies on the interrelationship between pyrimidine and urea synthesis in liver. Pausch J; Rasenack J; Häussinger D; Holstege A; Gerok W Adv Enzyme Regul; 1985; 24():233-43. PubMed ID: 3835821 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid. Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875 [TBL] [Abstract][Full Text] [Related]
16. Effects of acivicin and dichloroallyl lawsone upon pyrimidine biosynthesis in mouse L1210 leukemia cells. Kemp AJ; Lyons SD; Christopherson RI J Biol Chem; 1986 Nov; 261(32):14891-5. PubMed ID: 3771555 [TBL] [Abstract][Full Text] [Related]
17. N-(Phosphonacetyl)-L-aspartate inhibition of the enzyme complex of pyrimidine biosynthesis. Moore EC Biochem Pharmacol; 1982 Oct; 31(20):3313-6. PubMed ID: 7150357 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line. Chan TC; Howell SB Cancer Res; 1985 Aug; 45(8):3598-604. PubMed ID: 4016741 [TBL] [Abstract][Full Text] [Related]
19. Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis. Bhalla K; Grant S Cancer Chemother Pharmacol; 1987; 19(3):226-32. PubMed ID: 3581416 [TBL] [Abstract][Full Text] [Related]
20. Salvage of circulating pyrimidine nucleosides in the rat. Moyer JD; Oliver JT; Handschumacher RE Cancer Res; 1981 Aug; 41(8):3010-7. PubMed ID: 7248957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]